RTTNews | Jan 10, 2022 12:03PM EST

12:03 Monday, January 10, 2022 (RTTNews.com) - Shares of Bone Biologics Corp. (BBLG) are currently gaining nearly 80% on Monday morning. Jeffrey Frelick, the company's president and chief executive officer, is set to present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 - 13, 2022.

BBLG is currently trading at $6.11, up $2.68 or 78.13%, on the Nasdaq, on a heavy volume of 31 million shares, above average volume of 565 thousand shares.

Bone Biologics is a medical device company that focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration.

Read the original article on RTTNews ( https://www.rttnews.com/3253985/what-is-driving-bone-biologics-shares-up-80.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2022 RTTNews.com All Rights Reserved